Dr. Fanny C. F. IP is the Chief Scientific Officer at the Hong Kong Center for Neurodegenerative Diseases (HKCeND), established by The Hong Kong University of Science and Technology (HKUST). Her early research focused on synapse formation and the potential benefits of traditional Chinese medicine for neurodegenerative disorders. Recently, she has led clinical studies on blood biomarkers for early detection of Alzheimer's disease. Dr. Ip has published 70 scientific papers, holds 35 granted patents, and has successfully licensed AD therapeutics for clinical development, commercializing technologies that benefit the community.